| An ALK1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases MS Talkhoncheh, J Sjölund, P Bolivar, E Kurzejamska, E Cordero, ... | | 2024 |
| Molecular patterns of resistance to immune checkpoint blockade in melanoma M Lauss, B Phung, TH Borch, K Harbst, K Kaminska, A Ebbesson, ... Nature Communications 15 (1), 3075, 2024 | 2 | 2024 |
| An ALK1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases M Safaee Talkhoncheh, J Sjölund, P Bolivar, E Kurzejamska, E Cordero, ... bioRxiv, 2024.06. 15.599147, 2024 | | 2024 |
| 918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes A Draghi, CA Chamberlain, S Khan, K Harbst, M Presti, M Lauss, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Molecular patterns of resistance to immune checkpoint blockade in melanoma G Jonsson, M Lauss, B Phung, T Borch, K Harbst, K Kaminska, ... | | 2023 |
| Package ‘rocc’ M Lauss | 1 | 2022 |
| Package ‘swamp’ M Lauss, MM Lauss | | 2022 |
| DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype A Sanna, B Phung, S Mitra, M Lauss, J Choi, T Zhang, CN Njauw, ... JCI insight 7 (19), 2022 | 8 | 2022 |
| Tumour gene expression signature in primary melanoma predicts long-term outcomes (vol 12, 1137, 2021) M Garg, DL Couturier, J Nsengimana, NA Fonseca, M Wongchenko, ... NATURE COMMUNICATIONS 13 (1), 2022 | | 2022 |
| Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes M Garg, DL Couturier, J Nsengimana, NA Fonseca, M Wongchenko, ... Nature Communications 13 (1), 2841, 2022 | | 2022 |
| B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? M Lauss, M Donia, IM Svane, G Jönsson Clinical cancer research 28 (9), 1751-1758, 2022 | 58 | 2022 |
| Transcriptomic signatures of tumors undergoing T cell attack A Gokuldass, A Schina, M Lauss, K Harbst, CA Chamberlain, A Draghi, ... Cancer Immunology, Immunotherapy, 1-11, 2022 | 7 | 2022 |
| Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor … A Draghi, CA Chamberlain, S Khan, K Papp, M Lauss, S Soraggi, ... Frontiers in Immunology 12, 705422, 2021 | 18 | 2021 |
| BRN2 is a non-canonical melanoma tumor-suppressor M Hamm, P Sohier, V Petit, JH Raymond, V Delmas, M Le Coz, F Gesbert, ... Nature communications 12 (1), 3707, 2021 | 9 | 2021 |
| Tumour gene expression signature in primary melanoma predicts long-term outcomes M Garg, DL Couturier, J Nsengimana, NA Fonseca, M Wongchenko, ... Nature communications 12 (1), 1137, 2021 | 50 | 2021 |
| Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma TH Borch, K Harbst, AH Rana, R Andersen, E Martinenaite, P Kongsted, ... Journal for Immunotherapy of Cancer 9 (7), 2021 | 12 | 2021 |
| Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma (vol 33, pg 480, 2020) A Sanna, K Harbst, I Johansson, G Christensen, M Lauss, S Mitra, ... PIGMENT CELL & MELANOMA RESEARCH 34 (1), 144-144, 2021 | | 2021 |
| Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma … A Gokuldass, A Draghi, K Papp, TH Borch, M Nielsen, MCW Westergaard, ... Cancers 12 (11), 3344, 2020 | 23 | 2020 |
| Escape from nonsense-mediated decay associates with anti-tumor immunogenicity K Litchfield, JL Reading, EL Lim, H Xu, P Liu, M Al-Bakir, YNS Wong, ... Nature communications 11 (1), 3800, 2020 | 79 | 2020 |
| Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma S Mitra, M Lauss, R Cabrita, J Choi, T Zhang, K Isaksson, H Olsson, ... Molecular Oncology 14 (5), 933-950, 2020 | 33 | 2020 |
Göran JönssonProfessor, Dept. of Oncology, Clinical Sciences, Lund University, Sweden在 med.lu.se 的电子邮件经过验证
